Lack of CD56 expression on myeloma cells is not a marker for poor prognosis in patients treated by high-dose chemotherapy and is associated with translocation t(11;14)

✍ Scribed by Hundemer, M; Klein, U; Hose, D; Raab, M-S; Cremer, F W; Jauch, A; Benner, A; Heiß, C; Moos, M; Ho, A D

• Book ID: 110015482
• Publisher: Nature Publishing Group
• Year: 2007
• Tongue: English
• Weight: 143 KB
• Volume: 40
• Category: Article
• ISSN: 0007-1188
• DOI: 10.1038/sj.bmt.1705857